Home » Newsletters » BioWorld Science

BioWorld Science

May 29, 2003

View Archived Issues

No blood pressure effects found for statins in a "real-life" cohort of hypertensive patients

Novel antiallergic and antiinflammatory agents in Sumitomo pipeline

Shionogi presents new MMP inhibitors for COPD and other uses

Sodium channel blockers with analgesic activity identified at ICAgen

Bayer claims MKK4 and MKK7 inhibitors for inflammatory and immune disorders

Four series of analgesic agents patented by Gruenenthal researchers

Menarini scientists prepare and test novel tachykinin NK2 antagonists

Novel GSK-3beta inhibitors in early development at Janssen

Pioglitazone is well tolerated and improves the symptoms of nonalcoholic steatohepatitis

Good gastrointestinal safety profile reported for lumiracoxib in osteoarthritis

Evidence of clinical activity for rosiglitazone in Crohn's disease

New data on the effects of GI-181771 on the gastric function of humans

Atlizumab effective and well tolerated in refractory Crohn's disease

Ro-64-6198, an ORL1 agonist, inhibits citric acid-induced cough in guinea pigs

Rifalazil more effective than vancomycin against C. difficile infection in hamsters

Novel coxib R-109339 effective in a mouse model of adenomatous polyposis

AZD-3582 induces fewer ulcers as compared to naproxen in a rat refeeding model

Epix and Schering AG to develop novel MRI agents

Erbitux manufacturing milestone achieved

Phase III trials begin for Cerovive in acute ischemic stroke

Gedeon Richter to market and commercialize Avonex in Central & Eastern Europe

Salix board recommends rejection of Axcan's revised offer

High response rates reported for Trisenox in multiple myeloma

Indications for Viread expanded in E.U.

Genta reports Genasense clinical results

OXI-4503 the subject of Oxigene/Cancer Research UK collaboration

Livial studied for use in breast cancer patients

Preclinical results for microplasmin in posterior vitreous detachment

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...